
Who Is at Risk? Advancing Kidney Health in Diverse Populations
Sep 24, 2026 - 00:16:55
Radio and PodcastLive Radio & Podcasts
Dr. Saland summarizes the main findings from his study on "Final Results of the ILLUMINATE-A Phase 3 Clinical Trial of Lumasiran for Primary Hyperoxaluria 1.